{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T18:24:06Z","timestamp":1751912646718,"version":"3.37.3"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T00:00:00Z","timestamp":1553644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s40121-019-0242-5","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T02:02:45Z","timestamp":1553652165000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus"],"prefix":"10.1007","volume":"8","author":[{"given":"Kimberly C.","family":"Claeys","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan J.","family":"Zasowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trang D.","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony M.","family":"Casapao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M.","family":"Pogue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan P.","family":"Mynatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suprat S.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crystal","family":"Arthur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Welch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasif","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donald P.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Takla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen","family":"Rieck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonard B.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle P.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Hartman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Rybak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,27]]},"reference":[{"issue":"Suppl 3","key":"242_CR1","first-page":"iii35","volume":"65","author":"MS Dryden","year":"2010","unstructured":"Dryden MS. Complicated skin and soft tissue infection. J Antimicrob Chemother. 2010;65(Suppl 3):iii35\u201344.","journal-title":"J Antimicrob Chemother."},{"issue":"9","key":"242_CR2","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3201\/eid1509.081228","volume":"15","author":"J Edelsberg","year":"2009","unstructured":"Edelsberg J, Taneja C, Zervos M, Haque N, Moore C, Reyes K, et al. Trends in US hospital admissions for skin and soft tissue infections. Emerg Infect Dis. 2009;15(9):1516\u20138.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"242_CR3","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jemermed.2014.12.001","volume":"48","author":"CV Pollack","year":"2015","unstructured":"Pollack CV, Amin A, Ford WT, Finley R, Kaye KS, Nguyen HH, et al. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital. J Emerg Med. 2015;48(4):508\u201319.","journal-title":"J Emerg Med"},{"issue":"14","key":"242_CR4","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/archinte.168.14.1585","volume":"168","author":"AL Hersh","year":"2008","unstructured":"Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168(14):1585\u201391.","journal-title":"Arch Intern Med"},{"issue":"11","key":"242_CR5","doi-asserted-by":"publisher","first-page":"e0143276","DOI":"10.1371\/journal.pone.0143276","volume":"10","author":"KS Kaye","year":"2015","unstructured":"Kaye KS, Patel DA, Stephens JM, Khachatryan A, Patel A, Johnson K. Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact. PLoS One. 2015;10(11):e0143276.","journal-title":"PLoS One"},{"issue":"1","key":"242_CR6","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ajic.2010.03.018","volume":"39","author":"KMF Itani","year":"2011","unstructured":"Itani KMF, Merchant S, Lin S-J, Akhras K, Alandete JC, Hatoum HT. Outcomes and management costs in patients hospitalized for skin and skin-structure infections. Am J Infect Control. 2011;39(1):42\u20139.","journal-title":"Am J Infect Control"},{"issue":"7","key":"242_CR7","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1164\/rccm.201609-1848OC","volume":"196","author":"VX Liu","year":"2017","unstructured":"Liu VX, Fielding-Singh V, Greene JD, Baker JM, Iwashyna TJ, Bhattacharya J, et al. The timing of early antibiotics and hospital mortality in sepsis. Am J Respir Crit Care Med. 2017;196(7):856\u201363.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"242_CR8","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/cid\/ciu444","volume":"59","author":"DL Stevens","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJC, Gorbach SL, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59(2):147\u201359.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"242_CR9","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1086\/497143","volume":"41","author":"DL Stevens","year":"2005","unstructured":"Stevens DL, Bisno AL, Chambers HF, Everett ED, Dellinger P, Goldstein EJC, et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis. 2005;41(10):1373\u2013406.","journal-title":"Clin Infect Dis"},{"unstructured":"Food and Drug Administration (FDA). Non-inferiority clinical trials to establish effectiveness guidance for industry. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM202140.pdf [cited 2019 Jan 10].","key":"242_CR10"},{"issue":"Suppl 4","key":"242_CR11","first-page":"iv53","volume":"65","author":"MH Wilcox","year":"2010","unstructured":"Wilcox MH, Corey GR, Talbot GH, Thye D, Friedland D, Baculik T, et al. CANVAS 2: the second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65(Suppl 4):iv53\u201365.","journal-title":"J Antimicrob Chemother."},{"issue":"Suppl 4","key":"242_CR12","first-page":"iv41","volume":"65","author":"GR Corey","year":"2010","unstructured":"Corey GR, Wilcox MH, Talbot GH, Thye D, Friedland D, Baculik T. CANVAS 1: the first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections. J Antimicrob Chemother. 2010;65(Suppl 4):iv41\u201351.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"242_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"unstructured":"AHA Annual Survey | American Hospital Association\u2019s Annual Survey Database | AHA Data Online [Internet]. [cited 2019 Jan 10]. https:\/\/www.ahadataviewer.com\/additional-data-products\/AHA-Survey\/.","key":"242_CR14"},{"issue":"12","key":"242_CR15","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1592\/phco.27.12.1611","volume":"27","author":"SL Davis","year":"2007","unstructured":"Davis SL, McKinnon PS, Hall LM, Delgado G, Rose W, Wilson RF, et al. Daptomycin versus vancomycin for complicated skin and skin structure infections: clinical and economic outcomes. Pharmacotherapy. 2007;27(12):1611\u20138.","journal-title":"Pharmacotherapy."},{"key":"242_CR16","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1186\/s12879-015-1261-9","volume":"15","author":"TL Kauf","year":"2015","unstructured":"Kauf TL, McKinnon P, Corey GR, Bedolla J, Riska PF, Sims M, et al. An open-label, pragmatic, randomized controlled clinical trial to evaluate the comparative effectiveness of daptomycin versus vancomycin for the treatment of complicated skin and skin structure infection. BMC Infect Dis. 2015;15:503.","journal-title":"BMC Infect Dis"},{"issue":"3","key":"242_CR17","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1128\/JCM.01884-08","volume":"47","author":"DM Wolk","year":"2009","unstructured":"Wolk DM, Struelens MJ, Pancholi P, Davis T, Della-Latta P, Fuller D, et al. Rapid detection of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) in wound specimens and blood cultures: multicenter preclinical evaluation of the Cepheid Xpert MRSA\/SA skin and soft tissue and blood culture assays. J Clin Microbiol. 2009;47(3):823\u20136.","journal-title":"J Clin Microbiol."},{"issue":"8","key":"242_CR18","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1093\/cid\/ciw463","volume":"63","author":"T Bruun","year":"2016","unstructured":"Bruun T, Oppegaard O, Hufthammer KO, Langeland N, Skrede S. Early response in cellulitis: a prospective study of dynamics and predictors. Clin Infect Dis. 2016;63(8):1034\u201341.","journal-title":"Clin Infect Dis"},{"unstructured":"Dunne M. Abstract: concordance of clinical response at 48\u201372 hours after initiation of therapy and end of treatment (EOT) in patients with acute bacterial skin and skin structure infection (abSSSI) in the DISCOVER Studies (IDWeek 2013) [Internet]. Poster presented at: IDWeek 2013; 2013 [cited 2019 Jan 10]; San Fransisco. https:\/\/idsa.confex.com\/idsa\/2013\/webprogram\/Paper42449.html.","key":"242_CR19"},{"issue":"2","key":"242_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ijantimicag.2016.04.023","volume":"48","author":"D Nathwani","year":"2016","unstructured":"Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. Int J Antimicrob Agents. 2016;48(2):127\u201336.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"242_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1093\/cid\/ciw750","volume":"64","author":"D Nathwani","year":"2017","unstructured":"Nathwani D, Corey R, Das AF, Sandison T, De Anda C, Prokocimer P. Early clinical response as a predictor of late treatment success in patients with acute bacterial skin and skin structure infections: retrospective analysis of 2 randomized controlled trials. Clin Infect Dis. 2017;64(2):214\u20137.","journal-title":"Clin Infect Dis"},{"unstructured":"Food and Drug Administration (FDA). Guidance for industry acute bacterial skin and skin structure infections: developing drugs for treatment. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/ucm071185.pdf [cited 2019 Jan 10].","key":"242_CR22"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-0242-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-019-0242-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-019-0242-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T16:12:56Z","timestamp":1728922376000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-019-0242-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,27]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["242"],"URL":"https:\/\/doi.org\/10.1007\/s40121-019-0242-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"type":"print","value":"2193-8229"},{"type":"electronic","value":"2193-6382"}],"subject":[],"published":{"date-parts":[[2019,3,27]]},"assertion":[{"value":"9 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}